- Home
- SBGI vs NBTX Comparison
SBGI vs NBTX Comparison
Compare SBGI & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBGI | NBTX |
|---|---|---|
| Founded | 1986 | 2003 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2023 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SBGI | NBTX |
|---|---|---|
| Price | $14.09 | $33.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $21.80 | ★ $26.00 |
| AVG Volume (30 Days) | ★ 438.9K | 39.7K |
| Earning Date | 05-26-2026 | 01-01-0001 |
| Dividend Yield | ★ 7.22% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,169,000,000.00 | N/A |
| Revenue This Year | $12.59 | N/A |
| Revenue Next Year | N/A | $11.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.89 | $2.99 |
| 52 Week High | $17.88 | $41.89 |
Technical Indicators
Market Signals| Indicator | SBGI | NBTX |
|---|---|---|
| Relative Strength Index (RSI) | 43.80 | 57.18 |
| Support Level | $12.92 | $20.11 |
| Resistance Level | $14.32 | N/A |
| Average True Range (ATR) | 0.74 | 2.69 |
| MACD | -0.14 | 0.03 |
| Stochastic Oscillator | 21.56 | 47.72 |
Price Performance
Historical ComparisonAbout SBGI Sinclair Inc.
Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets, covering 40% of US households. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their premium sports content to pay-TV distributors.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.